ArticleAnnals of medicine and surgery (2012)2026

Daraxonrasib in metastatic pancreatic cancer (RASolute 302): survival breakthrough or real-world access barrier?

Muhammad Qaseem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.